JO984B1 - مركب صيدلي جاف ذو وحدة جرعية مناسبة للتعاطي عن طريق الفم - Google Patents

مركب صيدلي جاف ذو وحدة جرعية مناسبة للتعاطي عن طريق الفم

Info

Publication number
JO984B1
JO984B1 JO1977984A JOP19770984A JO984B1 JO 984 B1 JO984 B1 JO 984B1 JO 1977984 A JO1977984 A JO 1977984A JO P19770984 A JOP19770984 A JO P19770984A JO 984 B1 JO984 B1 JO 984B1
Authority
JO
Jordan
Prior art keywords
clavulanate
tri hydrate
amoxicillin trihydrate
hydrate formulations
potassium
Prior art date
Application number
JO1977984A
Other languages
English (en)
Inventor
جون كراولي باتريك
Original Assignee
بيتشام غروب ليمتد
جون كراولي باتريك
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO984(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by بيتشام غروب ليمتد, جون كراولي باتريك filed Critical بيتشام غروب ليمتد
Application granted granted Critical
Publication of JO984B1 publication Critical patent/JO984B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

مركب صيدلي جاف ذو وحدة جرعية مناسبة للتعاطي عن طريق الفم
JO1977984A 1977-10-11 1977-10-11 مركب صيدلي جاف ذو وحدة جرعية مناسبة للتعاطي عن طريق الفم JO984B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (1)

Publication Number Publication Date
JO984B1 true JO984B1 (ar) 1979-12-01

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
JO1977984A JO984B1 (ar) 1977-10-11 1977-10-11 مركب صيدلي جاف ذو وحدة جرعية مناسبة للتعاطي عن طريق الفم

Country Status (24)

Country Link
US (2) US4441609A (ar)
JP (1) JPS5476831A (ar)
AU (1) AU525089B2 (ar)
BE (1) BE870988A (ar)
CA (1) CA1105385A (ar)
CH (1) CH642258A5 (ar)
DE (1) DE2843318A1 (ar)
FR (1) FR2405711A1 (ar)
GB (1) GB2005538B (ar)
HK (1) HK73785A (ar)
IE (1) IE47450B1 (ar)
IL (1) IL55660A (ar)
IT (1) IT1109273B (ar)
JO (1) JO984B1 (ar)
KE (1) KE3525A (ar)
MT (1) MTP836B (ar)
MY (1) MY8500996A (ar)
NL (1) NL190631B (ar)
NZ (1) NZ188497A (ar)
PL (1) PL210174A1 (ar)
PT (1) PT68600A (ar)
SE (2) SE435899B (ar)
SG (1) SG34985G (ar)
ZA (1) ZA785682B (ar)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
AT353409B (de) * 1975-02-07 1979-11-12 Glaxo Lab Ltd Verfahren zum entfernen von verunreinigungen aus clavulansaeure oder deren salzen
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
GR70283B (ar) * 1979-10-02 1982-09-03 Beecham Group Ltd
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
EP0080862B1 (en) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
JPH10503739A (ja) * 1994-08-05 1998-04-07 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 感湿性物質用容器
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
WO1997009042A1 (en) * 1995-09-07 1997-03-13 Smithkline Beecham Corporation Pharmaceutical formulation
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
PL334976A1 (en) * 1997-02-14 2000-03-27 Smithkline Beecham Lab Pharmaceutic preparations containing amoxycyclin and clavulate
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
WO2001012184A1 (en) * 1999-08-16 2001-02-22 Revaax Pharmaceuticals, Llc Neurotherapeutic composition and method
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1541140A1 (en) * 2002-08-12 2005-06-15 Kyowa Hakko Kogyo Co., Ltd. Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
EP2465609B1 (en) 2007-06-21 2016-12-28 Gen-Probe Incorporated Method for mixing the contents of a detection chamber
EP2214680A4 (en) 2007-10-26 2010-12-29 Rexahn Pharmaceuticals Inc PHARMACEUTICAL FORMULATION OF CLAVLANIC ACID
CA2758029A1 (en) * 2009-04-29 2011-11-04 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus

Also Published As

Publication number Publication date
IT1109273B (it) 1985-12-16
NL7810176A (nl) 1979-04-17
MY8500996A (en) 1985-12-31
CA1105385A (en) 1981-07-21
KE3525A (en) 1985-05-31
IE782019L (en) 1979-04-11
US4441609A (en) 1984-04-10
IE47450B1 (en) 1984-03-21
PT68600A (en) 1978-10-01
NZ188497A (en) 1981-05-01
AU525089B2 (en) 1982-10-21
BE870988A (fr) 1979-04-03
GB2005538A (en) 1979-04-25
IL55660A (en) 1981-09-13
FR2405711B1 (ar) 1982-10-29
SG34985G (en) 1985-11-15
HK73785A (en) 1985-10-04
GB2005538B (en) 1982-05-26
SE435899B (sv) 1984-10-29
MTP836B (en) 1979-05-11
FR2405711A1 (fr) 1979-05-11
SE8107592L (sv) 1981-12-17
DE2843318A1 (de) 1979-04-12
US4301149A (en) 1981-11-17
SE7810591L (sv) 1979-04-12
CH642258A5 (de) 1984-04-13
IT7851415A0 (it) 1978-10-09
IL55660A0 (en) 1978-12-17
JPS6341886B2 (ar) 1988-08-19
SE451668B (sv) 1987-10-26
AU4050678A (en) 1980-04-17
NL190631B (nl) 1994-01-03
PL210174A1 (ar) 1980-08-11
ZA785682B (en) 1979-09-26
JPS5476831A (en) 1979-06-19

Similar Documents

Publication Publication Date Title
JO984B1 (ar) مركب صيدلي جاف ذو وحدة جرعية مناسبة للتعاطي عن طريق الفم
ES8307095A1 (es) Un procedimiento para la estabilizacion de una composicion farmaceutica de trihidrato de amoxicilina y de clavulanato depotasio.
CA2123321A1 (en) Combination chemotherapy
SG43037A1 (en) New esters of bi-and tricyclic aminoalcohols their preparation and their use in pharmaceutical compositions
AU2553992A (en) Bone-growth-stimulating composition
HUT49280A (en) Ointment for the peroral administration of medicine and process for producing the composition
IL91656A0 (en) Pharmaceutical composition containing a benzodiazepine derivative
MD1813C2 (ro) Derivaţi purificaţi de ciclodextrină ai eterilor sulfoalchilici sau amestecurile lor, complex clatrat al derivaţilor de ciclodextrină cu conţinut de medicament şi compoziţie farmaceutică
CA2227887A1 (en) Pharmaceutical compositions of conjugated estrogens and methods for their use
NZ337418A (en) Paracetamol composition with improved rate of absorption
IL50930A (en) 1-alkyl-4-oxo-1,6,7,8-tetrahydro-4h-pyrido(1,2-a)pyrimidine-3-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
ES8800040A1 (es) Procedimiento para la obtencion de una composicion farmaceutica de liberacion retardada a base de 9,10-dihidro-alcaloides.
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB2258397A (en) Pharmaceutical compositions containing amethocaine
GR3007347T3 (ar)
ES368325A1 (es) Un procedimiento para la preparacion de un compuesto de ce-falosporina.
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
GB1294538A (en) Pharmaceutical compositions
EP0003200A3 (en) Use of tetrahydropyridinyl indole derivatives as medicines, and pharmaceutical compositions containing them
IL41034A (en) 6-aza-3h-1,4-benzodiazepines and 6-aza-1,2-dihydro-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them
GB1446237A (en) Pharmaceutical preparations containing pyrazolones
KR940000108A (ko) 라이신 클로닉시네이트를 함유하는 약리학적 연질 캡슐 및 그것의 제조 방법
IL46755A (en) 2,3,8,12b-tetrahydro-1h-3a,8-methanodibenzo(3,4:6,7)-cyclohepta(1,2-c) pyrrole derivatives,their preparation and pharmaceutical compositions containing them
GB876320A (en) Pharmaceutical compositions containing d-3:5-diiodothyronine
CA1028248A (en) Pharmaceutical composition containing mg and k compounds